How have MPH shares performed in 2024?

Mereo BioPharma Group plc (MPH.L)'s stock was trading at GBX 26.50 at the start of the year. Since then, MPH shares have increased by 0.0% and is now trading at GBX 26.50. View the best growth stocks for 2024 here .

How were Mereo BioPharma Group plc (MPH.L)'s earnings last quarter?

Mereo BioPharma Group plc (MPH.L) (LON:MPH) announced its quarterly earnings data on Tuesday, September, 29th. The company reported ($105.00) EPS for the quarter.

What other stocks do shareholders of Mereo BioPharma Group plc (MPH.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mereo BioPharma Group plc (MPH.L) investors own include Enanta Pharmaceuticals (ENTA) , Advanced Micro Devices (AMD) , American Tower (AMT) , Inovio Pharmaceuticals (INO) , Micron Technology (MU) , Tesla (TSLA) , Amgen (AMGN) , ARMOUR Residential REIT (ARR) , Arena Pharmaceuticals (ARNA) and Ardelyx (ARDX) .

How do I buy shares of Mereo BioPharma Group plc (MPH.L)?

Shares of MPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:MPH

Mereo BioPharma Group plc (MPH.L) (MPH) Share Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free MPH Stock Alerts

GBX 26.50

-0.50 (-1.85%)

(As of 12/17/2020)

Compare

Today's Range: 26
▼
26.50
50-Day Range: 26.50
▼
26.50
52-Week Range: 13
▼
60

Volume: 49,264 shs
Average Volume: 333,975 shs
Market Capitalization: £89.76 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Mereo BioPharma Group plc (MPH.L) alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Mereo BioPharma Group plc (MPH.L) Stock (LON:MPH)

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company also develops Navicixizumab (OMP-305B83) that is in Phase 1a clinical trial for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that has completed Phase II clinical trial to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody, which is in Phase IIb clinical trial for the treatment of osteogenesis imperfect; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. Mereo BioPharma Group plc was founded in 2015 and is based in London, the United Kingdom.

MPH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MPH Stock News Headlines

April 18, 2024 | americanbankingnews.com

Mereo BioPharma Group plc (MPH.L) (LON:MPH) Stock Passes Below Fifty Day Moving Average of $26.50

April 14, 2024 | morningstar.com

Mereo BioPharma Group PLC ADR MREO

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 24, 2024 | msn.com

Mereo BioPharma Group plc - Depositary Receipt () (MREO) Price Target Increased by 17.65% to 5.10

February 23, 2024 | benzinga.com

Mereo BioPharma Group Stock (NASDAQ:MREO), Insider Trading Activity

February 22, 2024 | wsj.com

Mereo BioPharma Group PLC ADR

January 8, 2024 | msn.com

Mereo BioPharma provides update on pipeline progress, reaffirms cash runway guidance

January 8, 2024 | markets.businessinsider.com

BTIG Keeps Their Buy Rating on Mereo Biopharma Group Plc (MREO)

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

January 8, 2024 | markets.businessinsider.com

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

December 13, 2023 | seekingalpha.com

Mereo BioPharma: Lagging Stock Despite Positive Data

October 23, 2023 | markets.businessinsider.com

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

June 14, 2023 | markets.businessinsider.com

SVB Securities Sticks to Its Buy Rating for Mereo Biopharma Group Plc (MREO)

June 6, 2023 | msn.com

Ultragenyx, Mereo shares gain after positive results from study of bone disorder treatment

June 6, 2023 | msn.com

Ultragenyx, Mereo gain on Phase 2 data for bone disorder therapy

May 31, 2023 | technews.tmcnet.com

Mereo BioPharma to Present at the Jefferies Healthcare Conference

May 29, 2023 | msn.com

Navigating Mereo BioPharma's Future: Risky Proposition Despite Strides In Rare Disease Treatment

May 5, 2023 | msn.com

Mereo BioPharma transfers ADS listing from Nasdaq Global Market to Nasdaq Capital Market

May 5, 2023 | technews.tmcnet.com

Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market

March 28, 2023 | benzinga.com

Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights

March 21, 2023 | msn.com

Mereo soars ~25% after FDA, EMA guidance on main goals of trial for lung disease drug

December 21, 2022 | benzinga.com

Short Volatility Alert: Mereo Biopharma

October 28, 2022 | technews.tmcnet.com

Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management

October 17, 2022 | marketwatch.com

Mereo BioPharma Gets FDA Fast-Track Designation for Alvelestat >MREO

October 17, 2022 | markets.businessinsider.com

Mereo BioPharma: FDA Grants Fast Track Designation For Alvelestat - Quick Facts

October 5, 2022 | marketwatch.com

Rubric Capital Management Increases Slate of Proposed Mereo BioPharmaDirector Nominees to Five

September 26, 2022 | benzinga.com

Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putting Rubric Principal and Second New Director on the Board

See More Headlines

Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mereo BioPharma Group plc (MPH.L) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/29/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:MPH
CUSIP: N/A
CIK: N/A
Web: mereobiopharma.com
Phone: 44 33 3023 7300
Fax: N/A
Employees: 50
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 164.26
Current Ratio: 2.98
Quick Ratio: 2.92

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 17.12 per share
Price / Cash Flow: 1.55
Book Value: GBX 7.20 per share
Price / Book: 3.68

Miscellaneous

Outstanding Shares: 338,713,984
Free Float: N/A
Market Cap: £89.76 million
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Dr. Denise Scots-Knight (Age 61)
Co-Founder, CEO & Exec. Director
Comp: $751.37k
Mr. Charles Sermon (Age 51)
Co-Founder, Gen. Counsel & Company Sec.
Comp: $545.68k
Dr. Alastair MacKinnon (Age 50)
Co-Founder & Chief Medical Officer
Comp: $540.12k
Mr. John Richard (Age 63)
Co-Founder & Head of Corp. Devel.
Comp: $512.99k
Mr. Michael Stephen Wyzga MBA (Age 65)
Interim CFO & Exec. Director
Comp: $27.59k
Ms. Alexandra Hughes-Wilson (Age 49)
Head of Patient Access & Commercial Planning
Comp: $265.93k
Ms. Jill Henrich (Age 57)
US Site Head & Sr. VP of Regulatory Affairs
Comp: $286.93k
Dr. John A. Lewicki (Age 68)
Chief Scientific Officer
Dr. Fiona Bor
Head of Intellectual Property
Mr. Ian Hodgson
Head of Clinical Operations

Key Competitors

View All Competitors

MPH Stock Analysis - Frequently Asked Questions

How have MPH shares performed in 2024?: Mereo BioPharma Group plc (MPH.L)'s stock was trading at GBX 26.50 at the start of the year. Since then, MPH shares have increased by 0.0% and is now trading at GBX 26.50.
View the best growth stocks for 2024 here.
How were Mereo BioPharma Group plc (MPH.L)'s earnings last quarter?: Mereo BioPharma Group plc (MPH.L) (LON:MPH) announced its quarterly earnings data on Tuesday, September, 29th. The company reported ($105.00) EPS for the quarter.
What other stocks do shareholders of Mereo BioPharma Group plc (MPH.L) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Mereo BioPharma Group plc (MPH.L) investors own include Enanta Pharmaceuticals (ENTA), Advanced Micro Devices (AMD), American Tower (AMT), Inovio Pharmaceuticals (INO), Micron Technology (MU), Tesla (TSLA), Amgen (AMGN), ARMOUR Residential REIT (ARR), Arena Pharmaceuticals (ARNA) and Ardelyx (ARDX).
How do I buy shares of Mereo BioPharma Group plc (MPH.L)?: Shares of MPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:MPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Mereo BioPharma Group plc (MPH.L) (MPH) Share Price, News & Analysis

About Mereo BioPharma Group plc (MPH.L) Stock (LON:MPH)

MPH Stock Price History

MPH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MPH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info